Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.86
+0.01 (0.04%)
Nov 4, 2026, 12:49 PM EST - Market open
Organon & Co. Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,099 | 6,216 | 6,403 | 6,263 | 6,174 | 6,304 |
Revenue Growth | -3.21% | -2.92% | 2.23% | 1.44% | -2.06% | -3.49% |
Gross Profit Gross Profit Growth | 3,272 | 3,378 | 3,715 | 3,748 | 3,885 | 3,929 |
Operating Income Operating Income Growth | 1,205 | 1,293 | 1,497 | 1,329 | 1,712 | 1,921 |
Net Income Net Income Growth | 213 | 187 | 864 | 1,023 | 917 | 1,351 |
Earnings Per Share EPS Growth | 0.81 | 0.72 | 3.33 | 3.99 | 3.59 | 5.31 |
EPS Growth | -57.68% | -78.38% | -16.54% | 11.14% | -32.39% | -37.68% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Women's Health Women's Health Growth | 1,595 | 1,752 | 1,777 | 1,702 | 1,673 | 1,612 |
Biosimilars Biosimilars Growth | 768 | 691 | 662 | 593 | 481 | 424 |
Established Brands Established Brands Growth | 3,678 | 3,691 | 3,849 | 3,847 | 3,874 | 4,068 |
Other Product Group Other Product Group Growth | 58 | 82 | 115 | 121 | 146 | 200 |
Revenue (Total) Revenue (Total) Growth | 6,099 | 6,216 | 6,403 | 6,263 | 6,174 | 6,304 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,455 | 574 | 675 | 693 | 706 | 737 |
Total Debt Total Debt Growth | 8,554 | 8,800 | 9,036 | 8,931 | 9,112 | 9,364 |
Net Cash (Debt) Net Cash Growth | -7,099 | -8,226 | -8,361 | -8,238 | -8,406 | -8,627 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -26.61 | -31.55 | -32.26 | -32.15 | -32.94 | -33.94 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 843 | 700 | 939 | 799 | 858 | 2,458 |
Capital Expenditures CapEx Growth | -168 | -162 | -175 | -251 | -196 | -192 |
Free Cash Flow Free Cash Flow Growth | 675 | 538 | 764 | 548 | 662 | 2,266 |
Free Cash Flow Growth | -13.13% | -29.58% | 39.42% | -17.22% | -70.79% | 17.29% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.65% | 54.34% | 58.02% | 59.84% | 62.92% | 62.33% |
Operating Margin | 19.76% | 20.80% | 23.38% | 21.22% | 27.73% | 30.47% |
Pretax Margin | 8.25% | 6.84% | 12.60% | 10.75% | 18.17% | 24.25% |
Profit Margin | 3.49% | 3.01% | 13.49% | 16.33% | 14.85% | 21.43% |
FCF Margin | 11.07% | 8.65% | 11.93% | 8.75% | 10.72% | 35.95% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.080 | 0.340 | 1.120 | 1.120 | 1.120 | 0.560 |
Dividend Per Share Growth | -76.47% | -69.64% | 0% | 0% | 100.00% | - |
Dividend Yield | 0.58% | 4.75% | 7.51% | 7.77% | 4.01% | 1.84% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.12 | 9.97 | 4.45 | 3.60 | 7.75 | 5.72 |
Forward PE | 3.84 | 1.87 | 3.91 | 3.45 | 5.84 | 5.22 |
P/FCF Ratio | 5.39 | 3.47 | 5.03 | 6.73 | 10.73 | 3.41 |
PS Ratio | 0.60 | 0.30 | 0.60 | 0.59 | 1.15 | 1.23 |